BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19887416)

  • 1. Spurring new research for neglected diseases.
    Anderson GF
    Health Aff (Millwood); 2009; 28(6):1750-9. PubMed ID: 19887416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A business plan to help the 'global South' in its fight against neglected diseases.
    Frew SE; Liu VY; Singer PA
    Health Aff (Millwood); 2009; 28(6):1760-73. PubMed ID: 19887417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neglected tropical diseases: moving beyond mass drug treatment to understanding the science.
    Mahmoud A; Zerhouni E
    Health Aff (Millwood); 2009; 28(6):1726-33. PubMed ID: 19887413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in public-private partnerships to fight neglected diseases.
    Gustavsen K; Hanson C
    Health Aff (Millwood); 2009; 28(6):1745-9. PubMed ID: 19887415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R&D investments for neglected diseases can be sensitive to the economic goal of pharmaceutical companies.
    Dimitri N
    Drug Discov Today; 2012 Aug; 17(15-16):818-23. PubMed ID: 22414544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New models for pharmaceutical innovation in low-income countries.
    Ardal C; Iversen JH; Myhr K
    Tidsskr Nor Laegeforen; 2011 Oct; 131(20):2016-8. PubMed ID: 22016131
    [No Abstract]   [Full Text] [Related]  

  • 7. Building local research and development capacity for the prevention and cure of neglected diseases: the case of India.
    Kettler HE; Modi R
    Bull World Health Organ; 2001; 79(8):742-7. PubMed ID: 11545331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Turning neglected tropical diseases into forgotten maladies.
    Musgrove P; Hotez PJ
    Health Aff (Millwood); 2009; 28(6):1691-706. PubMed ID: 19887410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Status of research and development for control of tropical diseases: hypocrisy, indifference or lack of coordination].
    Millet P
    Med Trop (Mars); 2006 Dec; 66(6):542-8. PubMed ID: 17286017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New non-profit organization will support research to combat neglected diseases.
    Walgate R
    Bull World Health Organ; 2002; 80(10):842-3. PubMed ID: 12471410
    [No Abstract]   [Full Text] [Related]  

  • 11. Ask the experts.
    Pecoul B; Pollastri M; McKerrow J; Bueno-Calderon JM
    Future Med Chem; 2012 Jul; 4(11):1383-9. PubMed ID: 22857528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Talks restart on global initiative to fund research into diseases that affect poorer countries.
    Gulland A
    BMJ; 2013 Feb; 346():f702. PubMed ID: 23377793
    [No Abstract]   [Full Text] [Related]  

  • 13. Expanding the biopharmaceutical industry's involvement in fighting neglected diseases.
    Geraghty JA
    Health Aff (Millwood); 2009; 28(6):1774-7. PubMed ID: 19887418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donated drugs boost protection against neglected tropical diseases.
    Gulland A
    BMJ; 2013 Jan; 346():f351. PubMed ID: 23325895
    [No Abstract]   [Full Text] [Related]  

  • 15. A handful of 'antipoverty' vaccines exist for neglected diseases, but the world's poorest billion people need more.
    Hotez P
    Health Aff (Millwood); 2011 Jun; 30(6):1080-7. PubMed ID: 21653960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New generation of non-profit initiatives tackles world's "neglected" diseases.
    Mandelbaum-Schmid J
    Bull World Health Organ; 2004 May; 82(5):395-6. PubMed ID: 15298231
    [No Abstract]   [Full Text] [Related]  

  • 17. Global health: neglected diseases and access to medicines.
    Garg NJ
    Infect Dis Clin North Am; 2011 Sep; 25(3):639-51, ix-x. PubMed ID: 21896364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative and absolute addressability of global disease burden in maternal and perinatal health by investment in R&D.
    Fisk NM; McKee M; Atun R
    Trop Med Int Health; 2011 Jun; 16(6):662-8. PubMed ID: 21470349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on stimulating industrial research and development for neglected infectious diseases.
    Webber D; Kremer M
    Bull World Health Organ; 2001; 79(8):735-41. PubMed ID: 11545330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orphan drug legislation: lessons for neglected tropical diseases.
    Villa S; Compagni A; Reich MR
    Int J Health Plann Manage; 2009; 24(1):27-42. PubMed ID: 18435430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.